{"url_path":"/sec/lmri/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/2071288/0001193125-26-219480-index.html","accession_number":"0001193125-26-219480","cik":"0002071288","ticker":"LMRI","issuer_name":"Lumexa Imaging Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2071288/0001193125-26-219480-index.html","primary_entity_key":"0002071288","primary_entity_name":"Lumexa Imaging Holdings, Inc."},"word_count":89,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n(a) Disclosure in lieu of reporting on a Current Report on Form 8-K\n\nNone.\n\n(b) Material change to the procedures by which security holders may recommend nominees to the Board of Directors\n\nNone.\n\n(c) Insider Trading Arrangements and Policies\n\nDuring the quarterly period ended March 31, 2026, none of our officers (as defined in Rule 16a-1(f) under the Exchange Act) or directors adopted or terminated a Rule 10b5-1 trading plan or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).\n\n44"}